瑞思迈

Resmed Inc. Directors Sell Shares Amid Market Volatility.

ResMed's 15min chart shows MACD Death Cross, KDJ Death Cross signal.

ResMed

ResMed's Dominance in CPAP Market Expands with Wearables and Digital Tools.

ResMed's 15min chart: Bollinger Bands Narrowing, KDJ Death Cross detected.

ResMed's 15min chart sees MACD Death Cross, Bollinger Bands Narrowing.

Catalyst<ul> <li>Fund flows show positive net inflows across all order sizes including small, medium, large and extra-large.</li> <li>Most analysts rate RMD Buy or Strong Buy showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show market is in volatile state with unclear direction.</li> <li>Analyst ratings are mixed with three Neutral ratings citing valuation concerns.</li></ul>

Key Factors

ResMed Inc. [RMD] reported that Director Farrell Peter C sold 2000 shares at $251.31 per share on February 4, 2026. ResMed Inc. [RMD] also disclosed that Global General Counsel Rider Michael J sold 50 shares at $260 per share on February 4, 2026.

RMD News